While increasing numbers of studies have reported the expansion of GzmK-expressing CD8+ T cell populations in rheumatic disorders (15), the recognized role of extracellular GzmK in RA is currently restricted to pro-inflammatory cytokine production (19). This evidence concerns the gene CD8A and rheumatoid arthritis.